Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Trouble logging in?

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

2 days ago · The collaboration will leverage olivia, Tempus’ AI-enabled personal health concierge app that centralizes health data into a single platform and uses AI to make that information accessible, …

2 days ago · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma …

3 days ago · TEM expands its clinical software push with TIME trial-matching, Tempus Next care intelligence and an upgraded Tempus One AI assistant for providers.

Tempus Hub provides a secure platform for managing your Tempus-related activities and information.

4 days ago · The acquisition of a significant stake in Tempus AI by Clear Street Group, a prominent investment firm, signals confidence in the potential of the AI-driven healthcare company. Tempus …

15 hours ago · Wondering if Tempus AI is attractively priced or just riding hype? This article walks you through what the numbers actually say about its current valuation. The stock closed at US$50.84, …

Tempus is a healthcare technology company advancing the use of AI in precision oncology. By integrating comprehensive molecular and clinical data, we deliver actionable insights that help …